Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis

Journal of the American Academy of Dermatology

Volumn 68, Issue 4, 2013, Pages 609-617

  Ikeda, Shigaku ^a   Takahashi, Hidetoshi ^b   Suga, Yasushi ^a   Eto, Hikaru ^c   Etoh, Takafumi ^d   Okuma, Keiko ^a   Takahashi, Kazuo ^e   Kanbara, Takeshi ^f   Seishima, Mariko ^g   Morita, Akimichi ^h   Imai, Yasutomo ⁱ   Kanekura, Takuro ^j  

^a JUNTENDO UNIVERSITY   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^d TOKYO TEISHIN HOSPITAL   (Japan)

^e YOKOHAMA CITY UNIVERSITY   (Japan)

^f YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^g GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

ⁱ HYOGO COLLEGE OF MEDICINE   (Japan)

^j KAGOSHIMA UNIVERSITY   (Japan)

more..

Author keywords

Dermatology Life Quality Index; edema; erythroderma; generalized pustular psoriasis; granulocytapheresis; granulocyte and monocyte adsorption apheresis; granulocytes and monocytes; neutrophilic pustules

Indexed keywords

COLECALCIFEROL; CYCLOSPORIN; ETRETINATE; FC RECEPTOR; METHOTREXATE; PREDNISOLONE;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BONE MARROW CELL; CELL LINEAGE; CHILL; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; ERYTHRODERMA; FEMALE; GENERALIZED PUSTULAR PSORIASIS; GRANULOCYTE; HEADACHE; HUMAN; IMMUNOPATHOGENESIS; LEUKAPHERESIS; LEUKOCYTE; MALE; MONOCYTE; NEUTROPHIL; PHOTOTHERAPY; PRIORITY JOURNAL; PUSTULAR PSORIASIS; PUSTULE; QUALITY OF LIFE; SCORING SYSTEM; SKIN EDEMA; TREATMENT OUTCOME; TREATMENT RESPONSE; WEAKNESS;

ADULT; AGED; FEMALE; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; LEUKOCYTES; MALE; MIDDLE AGED; PSORIASIS;

EID: 84875424125     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.09.037     Document Type: Article

References (53)

1. U. Mrowietz, and K. Reich Psoriasis-new insights into pathogenesis and treatment Dtsch Arztebl Int 106 2009 11 18
2. G.R. Zanni Psoriasis: issues far more serious than cosmetic Consult Pharm 27 2012 86 88
3. G. Bens, F. Maccari, and E. Estève Psoriasis: a systemic disease [in French] Presse Med 41 2012 338 348
4. C.T. Ritchlin Strategies for biomarker development in psoriatic disease: a report from the GRAPPA 2010 Annual Meeting JRheumatol 39 2012 423 426
5. S.P. Raychaudhuri A cutting edge overview: psoriatic disease Clin Rev Allergy Immunol 2012 10.1007/s12016-012-8309-z Published online February 23, 2012
6. C.E.M. Griffiths, R.D.R. Camp, and J. Barker Psoriasis T. Burns, S. Breathnach, N. Cox, C. Griffiths, Rook's textbook of dermatology 7th ed. 2004 Blackwell Science Oxford 35.51 35.62
7. R. Shukuya, T. Hasegawa, Y. Niwa, K. Okuma, and S. Ikeda Granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis J Dermatol 38 2011 1130 1134
8. M. Seishima, Y. Mizutani, Y. Shibuya, C. Nagasawa, and T. Aoki Efficacy of granulocyte and monocyte adsorption apheresis for pustular psoriasis Ther Apher Dial 12 2008 13 18 (Pubitemid 351197448)
9. A. Michalak-Stoma, A. Pietrzak, J.C. Szepietowski, A. Zalewska-Janowska, T. Paszkowski, and G. Chodorowska Cytokine network in psoriasis revisited Eur Cytokine Netw 22 2011 160 168
10. E. Botti, G. Spallone, R. Caruso, G. Monteleone, S. Chimenti, and A. Costanzo Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target Curr Pharm Biotechnol 13 2012 1861 1867
11. L.M. Johnson-Huang, C.A. Pensabene, K.R. Shah, K.C. Pierson, T. Kikuchi, and T. Lentini Post-therapeutic relapse of psoriasis after CD11a blockade is associated with T cells and inflammatory myeloid DCs PLoS One 7 2012 e30308
12. A. Yoshifuku, K. Oyama, A. Ibusuki, M. Kawasaki, M. Sakanoue, and S. Matsushita Granulocyte and monocyte adsorption apheresis as an effective treatment for Reiter disease Clin Exp Dermatol 37 2012 241 244
13. T. Kanekura, Y. Mochitomi, S. Fujimoto, K. Kawahara, I. Maruyama, and T. Kanzaki Granulocyte and monocyte adsorption apheresis for leg ulcers in a patient with rheumatoid arthritis J Am Acad Dermatol 52 2005 1108 1109 (Pubitemid 40732566)
14. T. Kanekura, K. Kawahara, I. Maruyama, and T. Kanzaki Granulocyte and monocyte adsorption apheresis (GCAP) for refractory skin diseases caused by activated neutrophils and psoriatic arthritis: evidence that GCAP removes Mac-1-expressing neutrophils Ther Apher Dial 10 2006 247 256 (Pubitemid 43979295)
15. T. Fujisawa, K. Murase, Y. Okumura, H. Kanoh, T. Doi, and S. Yoshida Generalized pustular psoriasis successfully treated with granulocyte and monocyte adsorption apheresis Ther Apher Dial 15 2011 374 378
16. M. Viguier, A. Matthieu, A. Zagdanski, P. Bertheau, E. de Kerviler, and M. Rybojad High frequency of cholestasis in generalized pustular psoriasis: evidence for neutrophilic involvement of the biliary tract Hepatology 40 2004 452 458 (Pubitemid 39062863)
17. A.R. Saniabadi, H. Hanai, and I. Bjarnason Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes Ther Apher Dial 7 2003 48 59 (Pubitemid 36648043)
18. T. Ohmori, A. Yamagiwa, I. Nakamura, K. Nishikawa, and A.R. Saniabadi Treatment of pyoderma gangrenosum associated with Crohn's disease Am J Gastroenterol 98 2003 2101 2102 (Pubitemid 37185815)
19. A.R. Saniabadi, H. Hanai, and K. Fukunaga Therapeutic leukocytapheresis for inflammatory bowel disease Transfus Apher Sci 37 2007 191 200 (Pubitemid 350186259)
20. H. Hanai, Y. Takeda, R. Gruber, A.R. Saniabadi, O. Winqvist, and R. Lofberg The mode of actions of the Adacolumn therapeutic leukocytapheresis in patients with inflammatory bowel disease: a concise review Clin Exp Immunol 163 2011 50 58
21. S. Kato, E. Hosomi, F. Amano, T. Kobayashi, K. Kani, and R. Yamamoto The efficacy of intensive granulocyte and monocyte adsorption apheresis in a patient with Crohn's disease complicated by extensive subcutaneous aseptic neutrophilic abscesses J Crohns Colitis 6 2012 787 791
22. K. Ikeda, T. Hamada, M. Otsuka, and K. Iwatsuki Beneficial effects of neutrophil-targeted therapy for pyoderma gangrenosum associated with ulcerative colitis Eur J Dermatol 21 2011 804 805
23. T. Shimoyama, K. Sawada, N. Hiwatashi, and A.R. Saniabadi Safety and efficacy of granulocytes and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study J Clin Apher 16 2001 1 9
24. A. Sakuraba, S. Motoya, K. Watanabe, and T. Hibi An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment Am J Gastroenterol 104 2009 2990 2995
25. E. Domènech, J. Hinojosa, M. Esteve-Comas, F. Gomollón, J.M. Herrera, G. Bastida, and Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU) Granulocyteapheresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study Aliment Pharmacol Ther 20 2004 1347 1352 (Pubitemid 40040082)
26. B.E. Sands, W.J. Sandborn, and R. Löfberg A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis Gastroenterology 135 2008 400 409
27. T. Yamamoto, S. Umegae, and K. Matsumoto Daily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospective safety and feasibility study J Gastroenterol 4688 2011 1003 1009
28. T. Yamamoto, A.R. Saniabadi, S. Umegae, and K. Matsumoto Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: cytokine profiles and endoscopic findings Inflamm Bowel Dis 12 2006 719 726 (Pubitemid 44253756)
29. T. Hibi, Y. Sameshima, and Y. Sekiguchi Treating ulcerative colitis by Adacolumn therapeutic leukocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centers in Japan Dig Liver Dis 41 2009 570 577
30. K. Nagase, K. Fukunaga, K. Ohnishi, T. Kusaka, Y. Matoba, and K. Sawada Detection of specific IgE antibodies to nafamostat mesylate as an induction of possible adverse effects of leukocytapheresis using nafamostat mesylate as anticoagulant Ther Apher Dial 8 2004 45 51 (Pubitemid 38923763)
31. A.Y. Finlay, and G.K. Khan Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use Clin Exp Dermatol 19 1994 210 216 (Pubitemid 24194579)
32. G.S. Lazarus, F.J. Yost, and C.A. Thomas Polymorphonuclear leukocytes: possible mechanism of accumulation in psoriasis Science 198 1977 1162 1163 (Pubitemid 8241777)
33. M.C. Heng, J.A. Heng, and S.G. Allen Electron microscopic features in generalized pustular psoriasis Invest Dermatol 89 1987 187 191 (Pubitemid 17100077)
34. M.F. Abdel-Hamid, D.G. Aly, N.E. Saad, H.M. Emam, and D.F. Ayoub Serum levels of interleukin-8, tumor necrosis factor-α and γ-interferon in Egyptian psoriatic patients and correlation with disease severity J Dermatol 38 2011 442 446
35. T. Terui, M. Ozawa, and H. Tagami Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop Exp Dermatol 9 2000 1 10 (Pubitemid 30093030)
36. S. Yamashiro, J.M. Wang, D. Yang, W.H. Gong, H. Kamohara, and T. Yoshimura Expression of CCR6 and CD83 by cytokine-activated human neutrophils Blood 96 2000 3958 3963
37. Y. Umezawa, A. Ozawa, T. Kawasima, H. Shimizu, T. Terui, and H. Tagami Therapeutic guidelines for the treatment of generalized pustular psoriasis (GPP) based on a proposed classification of disease severity Arch Dermatol Res 295 Suppl 2003 S43 S54
38. J.H. Saurat, G. Stingl, and L. Dubertret Efficacy and safety results from the randomized controlled comparative study of adalimumab vs methotrexate vs placebo in patients with psoriasis (CHAMPION) Br J Dermatol 158 2008 558 566 (Pubitemid 351239154)
39. G. Girolomoni, G. Altomare, F. Ayala, E. Berardesca, P. Calzavara-Pinton, and S. Chimenti Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis Immunopharmacol Immunotoxicol 34 2012 548 560
40. H.Y. Chiu, T.S. Wang, Y.T. Cho, and T.F. Tsai Etanercept use for psoriasis in Taiwan: a case series study Int J Pharmacol 2012 10.1111/j.1365-4632.2011.05273.x Published online February 20, 2012
41. M.A. Cassatella The production of cytokines by polymorphonuclear neutrophils Immunol Today 16 1995 21 26
42. S. Nikolaus, J. Bauditz, and P. Gionchetti Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin-10 during intestinal inflammation Gut 42 1998 470 476 (Pubitemid 28186561)
43. G. Cullen, D. Kroshinsky, S. Cheifetz, and J.R. Korzenik Psoriasis associated with anti-tumor necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature Aliment Pharmacol Ther 34 2011 1318 1327
44. U. Wollina, G. Hansel, A. Koch, J. Schönlebe, E. Köstler, and G. Haroske Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients Am J Clin Dermatol 9 2008 1 14
45. H. Hanai, T. Iida, F. Watanabe, K. Takeuchi, and A. Saniabadi Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis Am J Gastroenterol 99 2004 1532 1538 (Pubitemid 39180103)
46. K.M. Mohler, D.S. Torrance, G.A. Smith, and M.B. Widmer Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists J Immunol 151 1993 1548 1561 (Pubitemid 23219293)
47. Y. Takeda, N. Shiobara, A.R. Saniabadi, M. Adachi, and K. Hiraishi Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: evidence for the involvement of plasma IgG, complement C3 and beta2 integrin Inflamm Res 53 2004 277 283 (Pubitemid 38969357)
48. C.A. Dinarello, and R.C. Thompson Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro Immunol Today 12 1991 404 410
49. Y. Tahara, A. Ido, S. Yamamoto, Y. Miyata, H. Uto, and T. Hori Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats J Pharmacol Exp Ther 307 2003 146 151 (Pubitemid 37151900)
50. ++ monocytes are a major source of TNF J Immunol 168 2002 3536 3542 (Pubitemid 34250422)
51. ++ monocytes in patients with inflammatory bowel disease Am J Gastroenterol 103 2008 1210 1216 (Pubitemid 351677962)
52. E. Cuadrado, M. Alonso, M.D. de Juan, P. Echaniz, and J.I. Arenas Regulatory T cells in patients with inflammatory bowel diseases treated with Adacolumn granulocytapheresis World J Gastroenterol 14 2008 1521 1527 (Pubitemid 351460165)
53. + T-cell subsets in patients with ulcerative colitis: modified by selective leukocytapheresis Dig Dis Sci 52 2007 2725 2731 (Pubitemid 47373881)